Injective INJ
Current Price
$3.36 +1.54%
$0.1500 Daily Range (4.46%)
$3.21$3.36
$47.71M Daily Volume
612 BTC
Vol/MktCap: 14.21%
Market Performance
0.10% Relative BTC Volume
The total volume of Injective is $47.71M over the past 24 hours, compared to $46.96B total Bitcoin volume.
Hourly Moving Average
8 SMA $3.29 +2.12%
13 SMA $3.27 +2.77%
21 SMA $3.28 +2.50%
55 SMA $3.28 +2.48%
144 SMA $3.31 +1.64%
Price Performance
+0.39% 1 Hour Change
$3.36 from $3.35
+11.83% 7 Day Change
$0.3976 from $2.96
+10.77% 14 Day Change
$0.3619 from $3.00
+13.99% 30 Day Change
$0.4700 from $2.89
All Time High
March 14, 2024
$52.62 -93.61%
-$49.26 vs. now
24H Change
5.49M USD +1.66%
70 BTC
Volume and Supply
Total Supply: 100.00M INJ 
100.00M INJ Available100.00% circulating A lower circulating supply may increase over time, reducing scarcity and potentially causing a drop in price. A higher circulating supply is less susceptible to dilution, offering the potential for a more stable price long-term.
Relative Supply Ratio
5.00 x BTC Supply5:1 supply ratio
RSR reflects potential differences in tokenomics, such as inflation rates, utility, or burn mechanisms, which can impact long-term value and scarcity.
Relative Trade Volume
14.52M INJ
traded over past 24 hours
14.52% of circulating supply
A higher trade volume relative to market cap indicates strong market activity and liquidity, while a lower ratio may suggest reduced interest, lower liquidity, or potential price stagnation.
Conversion Tool
Injective AI Market Analysis
Injective (INJ) is currently trading at $3.34, reflecting a 24-hour price increase of 1.36%. The daily price range has been relatively narrow, fluctuating between a high of $3.36 and a low of $3.21, indicating consolidation around the current price level.
The trading volume of 46,717,231 represents 13.97% of the market cap, suggesting healthy trading activity. Technical indicators show that short-term moving averages (8 SMA, 13 SMA, and 21 SMA) are trending positively, with the 8 SMA at $3.29 up by 1.52%, further supporting a bullish sentiment.
The 1-hour RSI at 65 indicates a strong momentum, signaling potential overbought conditions, while the 7-day RSI at 51 suggests a more balanced market position. Price changes over the past week (11.30%), two weeks (10.14%), and month (12.03%) demonstrate an overall upward trend, reinforcing bullish sentiment.
However, it's crucial to note that the all-time high of $52.62, achieved in March 2024, highlights significant downward pressure from historical levels. The current price remains significantly below this peak, indicating room for growth but also risk associated with a possible correction.
Given the current bullish indicators, including positive short-term moving averages and an increasing RSI, the outlook for Injective (INJ) appears favorable in the near term. However, the substantial distance from its all-time high and overbought conditions in the short term warrant caution.
In conclusion, I recommend a Hold rating for Injective (INJ). This reflects a balanced approach, allowing investors to capture potential gains while remaining aware of market volatility and historical price levels.
The trading volume of 46,717,231 represents 13.97% of the market cap, suggesting healthy trading activity. Technical indicators show that short-term moving averages (8 SMA, 13 SMA, and 21 SMA) are trending positively, with the 8 SMA at $3.29 up by 1.52%, further supporting a bullish sentiment.
The 1-hour RSI at 65 indicates a strong momentum, signaling potential overbought conditions, while the 7-day RSI at 51 suggests a more balanced market position. Price changes over the past week (11.30%), two weeks (10.14%), and month (12.03%) demonstrate an overall upward trend, reinforcing bullish sentiment.
However, it's crucial to note that the all-time high of $52.62, achieved in March 2024, highlights significant downward pressure from historical levels. The current price remains significantly below this peak, indicating room for growth but also risk associated with a possible correction.
Given the current bullish indicators, including positive short-term moving averages and an increasing RSI, the outlook for Injective (INJ) appears favorable in the near term. However, the substantial distance from its all-time high and overbought conditions in the short term warrant caution.
In conclusion, I recommend a Hold rating for Injective (INJ). This reflects a balanced approach, allowing investors to capture potential gains while remaining aware of market volatility and historical price levels.
Updated 43 minutes ago.
Injective Relative Price at Market Cap of:
Injective TradingView Chart
In The News

Military planners meet in London to discuss reopening Strait of Hormuz
The meeting underscores potential military action, highlighting geopolitical tensions and market uncertainty over swift diplomatic solutions.

SoFi Adds XRP Deposits: Ripple Says Broader Access Brings More Participation and Utility
XRP deposits have been enabled on SoFi, expanding regulated crypto access for U.S. retail users.

Solana outpaces Ethereum with 25.3B transactions – Will SOL/ETH finally react?
Developer-led on-chain expansion strengthens the case for a structural SOL/ETH breakout narrative.

Bitcoin surges past $77K as $40M in shorts liquidated amid US-Iran tensions
Bitcoin's surge highlights its role as a geopolitical hedge, potentially increasing institutional interest and market volatility.